STOCK TITAN

iAnthus Provides Update on Annual General Meeting

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

iAnthus Capital Holdings announced an update regarding its Annual General Meeting (AGM) for 2020. The BC Registrar extended the deadline for the AGM to December 31, 2021, but later declined further extensions. In response, iAnthus filed a Notice of Appeal in the Supreme Court of British Columbia, seeking an extension until June 30, 2022, due to pending recapitalization transactions. The company emphasizes potential impacts from COVID-19 on operations, which may affect financial performance and share trading.

Positive
  • Filed an appeal for extension to hold the 2020 AGM until June 30, 2022, allowing for ongoing recapitalization efforts.
Negative
  • The BC Registrar has denied further extensions for the AGM, potentially leading to compliance issues.
  • Ongoing impacts from COVID-19 could disrupt operations and adversely affect financial results.

NEW YORK and TORONTO, Dec. 17, 2021 /PRNewswire/ - iAnthus Capital Holdings, Inc. ("iAnthus" or the "Company") (CSE: IAN, OTCPK: ITHUF), which owns, operates and partners with regulated cannabis operations across the United States, provides an update with respect to the Company's Annual General Meeting. As disclosed in the Company's news release dated November 4, 2021, The BC Registrar of Companies (the "BC Registrar") granted a further extension extending the deadline to hold the Company's Annual General Meeting for the year 2020 (the "2020 AGM") from October 31, 2021 to December 31, 2021.  On November 19, 2021, the BC Registrar declined to grant any further extension for the Company to hold the 2020 AGM, citing its policy of allowing maximum extensions of 12 months.

Today, iAnthus filed a Notice of Appeal in the Supreme Court of British Columbia appealing the BC Registrar's decision further to section 406 of the British Columbia Business Corporations Act, SBC 2002, c 57 (the "Appeal").  iAnthus asks the court for an extension to hold the 2020 AGM to June 30, 2022 as, among other things, the Company's previously announced recapitalization transaction has not yet closed. No hearing date for the Appeal has yet been scheduled yet.

About iAnthus

iAnthus owns and operates licensed cannabis cultivation, processing and dispensary facilities throughout the United States. For more information, visit www.iAnthus.com.

COVID-19 Risk Factor

The Company may be impacted by business interruptions resulting from pandemics and public health emergencies, including those related to COVID-19. An outbreak of infectious disease, a pandemic, or a similar public health threat, such as the recent outbreak of COVID-19, or a fear of any of the foregoing could adversely impact the Company by causing operating, manufacturing, supply chain, and project development delays and disruptions, labor shortages, travel, and shipping disruption and shutdowns (including as a result of government regulation and prevention measures). It is unknown whether and how the Company may be affected if such a pandemic persists for an extended period of time, including as a result of the waiver of regulatory requirements or the implementation of emergency regulations to which the Company is subject. Although the Company has been deemed essential and/or has been permitted to continue operating its facilities in the states in which it cultivates, processes, manufactures, and sells cannabis during the pendency of the COVID-19 pandemic, there is no assurance that the Company's operations will continue to be deemed essential and/or will continue to be permitted to operate. The Company may incur expenses or delays relating to such events outside of its control, which could have a material adverse impact on its business, operating results, financial condition, and the trading price of the Company's common shares.

Forward-Looking Statements

Statements in this news release contain forward-looking statements. These forward-looking statements are made on the basis of the current beliefs, expectations and assumptions of management, are not guarantees of performance and are subject to significant risks and uncertainty. These forward-looking statements should, therefore, be considered in light of various important factors, including those set forth in Company's reports that it files from time to time with the SEC and the Canadian securities regulators, which you should review including, but not limited to, the Company's Annual Report on Form 10-K filed with the SEC. When used in this news release, words such as "will," could," plan," estimate," expect," intend," may," potential," believe, "should" and similar expressions, are forward-looking statements. Forward-looking statements may include, without limitation, statements relating to the Company's financial performance, business development and results of operations and the timing and outcome of the closing of the Recapitalization Transaction.

These forward-looking statements should not be relied upon as predictions of future events, and the Company cannot assure you that the events or circumstances discussed or reflected in these statements will be achieved or will occur. If such forward-looking statements prove to be inaccurate, the inaccuracy may be material. You should not regard these statements as a representation or warranty by the Company or any other person that it will achieve its objectives and plans in any specified timeframe, or at all. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this news release. The Company disclaims any obligation to publicly update or release any revisions to these forward-looking statements, whether as a result of new information, future events or otherwise, after the date of this news release or to reflect the occurrence of unanticipated events, except as required by law.

Neither the Canadian Securities Exchange or The Securities Exchange Commission have reviewed, approved or disapproved the content of this news release.

Cision View original content:https://www.prnewswire.com/news-releases/ianthus-provides-update-on-annual-general-meeting-301447737.html

SOURCE iAnthus Capital Holdings, Inc.

FAQ

What is the status of iAnthus Capital Holdings' Annual General Meeting?

iAnthus has filed an appeal for an extension to hold the 2020 AGM until June 30, 2022, after the BC Registrar denied further extensions.

What financial implications does COVID-19 pose for iAnthus Capital Holdings?

COVID-19 may cause operational disruptions, impacting financial performance and the trading price of ITHUF shares.

What was the deadline for iAnthus Capital Holdings to hold the 2020 AGM?

The deadline was extended to December 31, 2021, after which the BC Registrar declined further extensions.

IANTHUS CAPITAL HLDG ORD

OTC:ITHUF

ITHUF Rankings

ITHUF Latest News

ITHUF Stock Data

33.39M
3.61B
7.34%
85.18%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
United States of America
Toronto